Men's Health
Conference Coverage
Male contraceptive pill appears feasible in very early trials
By lowering testosterone levels without untoward hypogonadism, early data show that once-daily contraceptive pills for men could be feasible.
Conference Coverage
Jury still out on cardiovascular safety of testosterone
A meta-analysis may provide some reassurance of the short-term cardiovascular safety of testosterone therapy for male hypogonadism until...
From the Journals
‘Medical maximizers’ dole out unneeded antibiotics for ASB
Why are patients with asymptomatic UTIs receiving treatment?
Latest News
New test might transform male infertility
The test detects unstable gene promotors, which are the epigenetic markers for gene expression.
Latest News
Double the pleasure: Stim patch delays early ejaculation: Study
“The miniaturized perineal stimulation device may become an on-demand, drug-free therapeutic option.”
From the Journals
Takotsubo syndrome more deadly in men
Takotsubo syndrome, characterized by acute heart failure and transient ventricular contractile dysfunction, is more common in women but men are...
Conference Coverage
AUA 2022: A report from the trenches
Hundreds of talks and abstracts were presented over the 4 days in New Orleans.
From the Journals
Male breast cancer risk linked with infertility
“This study helps to shed light onto a cancer type that is sadly still not very well understood, but much more research is needed to say that...
Conference Coverage
New guideline gives active surveillance a boost
This is the first guidance for localized prostate cancer since 2017.
Conference Coverage
Most men with low-risk prostate tumors now forgoing treatment
Roughly 60% of men eligible for active surveillance chose that approach in 2021, up from 27% in 2014 and less than 10% in 2010.
Conference Coverage
Abaloparatide works in ‘ignored population’: Men with osteoporosis
Study finds increased bone mineral density from baseline to 1 year in men with osteoporosis.